Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Shire's new HGT team, the former TKT, specializes in discovering, developing and commercializing protein therapeutics primarily for the treatment of genetic diseases. This business extends Shire's reach by strengthening its portfolio and pipeline with a range of new therapeutic possibilities for patients suffering with genetic diseases.

List your booth number for exhibitions, ask us